Evolva Holding en liquidation (Evolva Holding en liquidation) Debt-to-Equity : 0.58 (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Evolva Holding en liquidation Debt-to-Equity?

Evolva Holding en liquidation's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $15.22 Mil. Evolva Holding en liquidation's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $3.40 Mil. Evolva Holding en liquidation's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $32.00 Mil. Evolva Holding en liquidation's debt to equity for the quarter that ended in Jun. 2023 was 0.58.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Evolva Holding en liquidation's Debt-to-Equity or its related term are showing as below:

ELVYY' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.58
Current: 0.58

During the past 13 years, the highest Debt-to-Equity Ratio of Evolva Holding en liquidation was 0.58. The lowest was 0.01. And the median was 0.04.

ELVYY's Debt-to-Equity is ranked worse than
77.52% of 1081 companies
in the Biotechnology industry
Industry Median: 0.15 vs ELVYY: 0.58

Evolva Holding en liquidation Debt-to-Equity Historical Data

The historical data trend for Evolva Holding en liquidation's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding en liquidation Debt-to-Equity Chart

Evolva Holding en liquidation Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.04

0.06

0.08

0.14

Evolva Holding en liquidation Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial															0.11	0.08	0.11	0.14	0.58

Competitive Comparison of Evolva Holding en liquidation's Debt-to-Equity

For the Biotechnology subindustry, Evolva Holding en liquidation's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolva Holding en liquidation's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding en liquidation's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Evolva Holding en liquidation's Debt-to-Equity falls into.

Evolva Holding en liquidation Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Evolva Holding en liquidation's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13.043	+	3.12)	/	114.039
	=	0.14

Evolva Holding en liquidation's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.218	+	3.396)	/	32.004
	=	0.58

Evolva Holding en liquidation (OTCPK:ELVYY) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Evolva Holding en liquidation Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Evolva Holding en liquidation's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding en liquidation (Evolva Holding en liquidation) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA en liquidation (OTCPK:ELVYY) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

ELVAF:USA EVEz:UK EVE:Switzerland

Address

Duggingerstrasse 23, Reinach, CHE, CH-4153

Website

https://www.evolva.com

Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding en liquidation (Evolva Holding en liquidation) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research • 02-13-2024